Literature DB >> 4028419

Masked presentation of giant-cell arteritis.

W S Wilke, A J Wysenbeek, P L Krall, A M Segal.   

Abstract

Entities:  

Mesh:

Year:  1985        PMID: 4028419     DOI: 10.3949/ccjm.52.2.155

Source DB:  PubMed          Journal:  Cleve Clin Q        ISSN: 0009-8787


× No keyword cloud information.
  5 in total

1.  A comparison of the sensitivity of diagnostic criteria for polymyalgia rheumatica.

Authors:  H A Bird; B F Leeb; C M Montecucco; N Misiuniene; G Nesher; S Pai; C Pease; J Rovensky; B Rozman
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

Review 2.  Diagnosis, differential diagnosis and treatment of polymyalgia rheumatica.

Authors:  Thomas Nothnagl; Burkhard F Leeb
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

3.  A disease activity score for polymyalgia rheumatica.

Authors:  B F Leeb; H A Bird
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

4.  Clinical characteristics and prognostic factors for relapse in patients with polymyalgia rheumatica (PMR).

Authors:  Jung Hwa Lee; Sang Tae Choi; Jin Su Kim; Bo Young Yoon; Seung-Ki Kwok; Hyun-Sook Kim; Yun Sung Kim; Jung-Soo Song; Sang-Heon Lee; Hae-Rim Kim
Journal:  Rheumatol Int       Date:  2012-11-27       Impact factor: 2.631

5.  EULAR response criteria for polymyalgia rheumatica: results of an initiative of the European Collaborating Polymyalgia Rheumatica Group (subcommittee of ESCISIT).

Authors:  B F Leeb; H A Bird; G Nesher; I Andel; W Hueber; D Logar; C M Montecucco; J Rovensky; J Sautner; M Sonnenblick
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.